BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT mouse model of tauopathy is a research paper published in Neuroscience Letters (2023). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
RRD VA
Grant: I21 RX003459
NIA NIH HHS
Grant: P30 AG019610
BLRD VA
Grant: I01 BX004067
NIA NIH HHS
Grant: P30 AG066514
RRD VA
Grant: I01 RX000684
RRD VA
Grant: I01 RX002333
RRD VA
Grant: I01 RX003846
NIA NIH HHS
Grant: P30 AG072980
RRD VA
Grant: I01 RX002660
NIA NIH HHS
Grant: P30 AG062429
MeSH Terms
Keywords